Որոնման արդյունքները - Tim Fessenden
- Ցուցադրվում են 1 - 4 արդյունքները 4
-
1
Tissue Site and the Cancer Immunity Cycle Brendan Horton, Tim Fessenden, Stefani Spranger
Հրապարակվել է 2019Revisão -
2
Type I interferon activates MHC class I-dressed CD11b+ conventional dendritic cells to promote protective anti-tumor CD8+ T cell immunity Ellen Duong, Tim Fessenden, Emi A. Lutz, Teresa Dinter, Leon Yim, Sarah E. Blatt, Arjun Bhutkar, K. Dane Wittrup, Stefani Spranger
Հրապարակվել է 2021Artigo -
3
Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer Steven Kregel, James L. Chen, Westin R. Tom, Venkatesh Krishnan, Jacob Kach, Hannah Brechka, Tim Fessenden, Masis Isikbay, Gladell P. Paner, Russell Z. Szmulewitz, Donald J. Vander Griend
Հրապարակվել է 2016Artigo -
4
Deciphering the immunopeptidome in vivo reveals new tumour antigens Alex M. Jaeger, Lauren Stopfer, Ryuhjin Ahn, Emma A. Sanders, Demi Sandel, William A. Freed-Pastor, William M. Rideout, Santiago Naranjo, Tim Fessenden, Kim B. Nguyen, Peter Winter, Ryan Kohn, Peter M.K. Westcott, Jason M. Schenkel, Sean-Luc Shanahan, Alex K. Shalek, Stefani Spranger, Forest M. White, Tyler Jacks
Հրապարակվել է 2022Artigo
Որոնման գործիքներ:
Առնչվող խորագիր
Cancer research
Biology
Immune system
Immunology
Antigen
CD8
Cancer
Genetics
Internal medicine
MHC class I
Major histocompatibility complex
Medicine
T cell
Androgen receptor
Antigen presentation
Cancer immunotherapy
Cross-presentation
Cytotoxic T cell
Dendritic cell
Enzalutamide
Immune checkpoint
Immunity
Immunosurveillance
Immunotherapy
In vitro
In vivo
Interferon
LNCaP
MHC class II
Molecular biology